Protocol Development and Quality Improvement
1.β Discontinue drug
2.β Switch drug
3.β Switch drug for less expensive but equally safe
and effective drug
4.β Drug dosing
5.β Drug dosage form
6.β Drug route
7.β Pharmacokinetic consultation
9.β IV-to-PO switch therapy
10.β Contraindication
11.β Duplicate therapy
12.β Nonformulary switch to formulary
13.β Nonformulary approval
14.β Drug unavailable
15.β IV drug incompatibility
16.β Drug-drug interaction
17.β Drug-food interaction
18.β Drug-laboratory test interaction
19.β Pharmacogenomics interaction
20.β Therapeutic interchange
22.β Medication reconciliation
23. Transfer medication reconciliation
24. Discharge medication reconciliation
25.β Discharge counseling
26.β Written patient education provided
27.β Patient adherence to medications
28.β Adverse drug reaction
29.β Overdosage
30.β Subtherapeutic dose
31.β Medication error identification and avoidance
32.β Monitoring for efficacy
33.β Monitoring for toxicity
34.β Ordering laboratory tests for monitoring drug
efficacy and toxicity
35.β Clarification of medication order
36.β Untreated indication
37.β Failure to receive medication
38.β Immunization recommendation
39.β Immunization administered
40.β Health risk assessment
41.β Rapid response interventions
42.β Code interventions
43.β CDTM interventions
CDTM = collaborative drug therapy management.
Clinical Interventions
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
Clinical Interventions